Hydrocortisone 1% cream and sertaconazole 2% cream to treat facial seborrheic dermatitis: A double-blind, randomized clinical trial K. Balighi, S.Z. Ghodsi, M. Daneshpazhooh, S. Ghale-Baghi, M. Nasimi, A. Azizpour International Journal of Women's Dermatology Volume 3, Issue 2, Pages 107-110 (June 2017) DOI: 10.1016/j.ijwd.2016.11.008 Copyright © 2016 The Authors Terms and Conditions
Fig. 1 Within-group decrease in seborrhea score from baseline to study end (p < .05 for both treatment groups). There was no significant difference between the treatment groups at any timepoint. International Journal of Women's Dermatology 2017 3, 107-110DOI: (10.1016/j.ijwd.2016.11.008) Copyright © 2016 The Authors Terms and Conditions
Fig. 2 Within-group decrease in patient satisfaction from baseline to study end (p < .05 for both treatment groups). There was no significant difference between the treatment groups at any timepoint. International Journal of Women's Dermatology 2017 3, 107-110DOI: (10.1016/j.ijwd.2016.11.008) Copyright © 2016 The Authors Terms and Conditions